Development and validation of different indirect ELISAs for MERS-CoV serological testing
- 16 January 2019
- journal article
- research article
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 466, 41-46
- https://doi.org/10.1016/j.jim.2019.01.005
Abstract
No abstract availableKeywords
Funding Information
- King Abdulaziz City for Science and Technology (09-1)
This publication has 31 references indexed in Scilit:
- Transmission of MERS-Coronavirus in Household ContactsThe New England Journal of Medicine, 2014
- Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV casesJournal of Clinical Virology, 2014
- Evidence for Camel-to-Human Transmission of MERS CoronavirusThe New England Journal of Medicine, 2014
- Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical DescriptionClinical Infectious Diseases, 2014
- Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi ArabiamBio, 2014
- Serological assays for emerging coronaviruses: Challenges and pitfallsVirus Research, 2014
- Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging CoronavirusesThe Journal of Infectious Diseases, 2013
- A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoVVirology Journal, 2013
- Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study GroupJournal of Virology, 2013
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaThe New England Journal of Medicine, 2012